Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Haemodynamic effects of fludrocortisone and midodrine in patients with symptoms due to hypotension

de Lange, Frederik J ; van Zanten, Steven ; Rivasi, Giulia ; Groppelli, Antonella ; Russo, Vincenzo ; Maggi, Roberto ; Capacci, Marco ; Nawaz, Sara ; Comune, Angelo and Ungar, Andrea , et al. (2024) In Clinical autonomic research : official journal of the Clinical Autonomic Research Society
Abstract

AIM: The study aimed to assess the haemodynamic effects of fludrocortisone and midodrine, alone or combined, in patients with recurrent syncope and/or symptoms due to hypotension and ≥ 1 daytime systolic blood pressure (SBP) drop < 90 mmHg or ≥ 2 daytime SBP drops < 100 mmHg recorded by 24-h ambulatory blood pressure monitoring (ABPM1).

METHOD: A total of 53 patients (mean age, 40.9 ± 18.5 years, 37 female) were treated with fludrocortisone (0.05-0.2 mg per day) and/or midodrine (2.5-10 mg two or three times per day). A second ABPM (ABPM2) was performed within 6 months and the results of ABPM1 AND ABPM2 were compared to assess the effects of BP-rising drugs.

RESULTS: In 32 patients assigned to fludrocortisone, 24-h SBP... (More)

AIM: The study aimed to assess the haemodynamic effects of fludrocortisone and midodrine, alone or combined, in patients with recurrent syncope and/or symptoms due to hypotension and ≥ 1 daytime systolic blood pressure (SBP) drop < 90 mmHg or ≥ 2 daytime SBP drops < 100 mmHg recorded by 24-h ambulatory blood pressure monitoring (ABPM1).

METHOD: A total of 53 patients (mean age, 40.9 ± 18.5 years, 37 female) were treated with fludrocortisone (0.05-0.2 mg per day) and/or midodrine (2.5-10 mg two or three times per day). A second ABPM (ABPM2) was performed within 6 months and the results of ABPM1 AND ABPM2 were compared to assess the effects of BP-rising drugs.

RESULTS: In 32 patients assigned to fludrocortisone, 24-h SBP increased from 107.1 ± 9.9 mmHg to 116.3 ± 14.9 (p = 0.0001), the number of daily SBP drops < 90 mmHg decreased by 73% (p = 0.0001) and that of drops < 100 mmHg decreased by 41% (p = 0.0005). In 14 patients assigned to midodrine, 24-h SBP increased from 112.7 ± 7.4 mmHg to 115.0 ± 9.1 (p = 0.12), the number of daily SBP drops < 90 mmHg decreased by 52% (p = 0.04) and that of drops < 100 mmHg decreased by 34% (p = 0.007). In the seven patients taking both fludrocortisone and midodrine, 24-h SBP increased from 110.1 ± 11.5 mmHg to 114.0 ± 12.4 (p = 0.002), the number of daily SBP drops < 90 mmHg decreased by 69% (p = 0.22) and that of drops < 100 mmHg decreased by 44% (p = 0.04).

CONCLUSIONS: Both fludrocortisone and midodrine effectively increased 24-h SBP and reduced SBP drops on ABPM but fludrocortisone seemed to be more effective than midodrine. Further randomised studies are needed to confirm these observations.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; and (Less)
publishing date
type
Contribution to journal
publication status
epub
subject
in
Clinical autonomic research : official journal of the Clinical Autonomic Research Society
publisher
Springer
external identifiers
  • pmid:39718670
  • scopus:85212844416
ISSN
1619-1560
DOI
10.1007/s10286-024-01096-3
language
English
LU publication?
no
additional info
© 2024. Springer-Verlag GmbH Germany.
id
ef1f2fdf-dd62-43a5-975d-0a379d87f963
date added to LUP
2024-12-30 20:12:37
date last changed
2025-07-15 19:58:51
@article{ef1f2fdf-dd62-43a5-975d-0a379d87f963,
  abstract     = {{<p>AIM: The study aimed to assess the haemodynamic effects of fludrocortisone and midodrine, alone or combined, in patients with recurrent syncope and/or symptoms due to hypotension and ≥ 1 daytime systolic blood pressure (SBP) drop &lt; 90 mmHg or ≥ 2 daytime SBP drops &lt; 100 mmHg recorded by 24-h ambulatory blood pressure monitoring (ABPM1).</p><p>METHOD: A total of 53 patients (mean age, 40.9 ± 18.5 years, 37 female) were treated with fludrocortisone (0.05-0.2 mg per day) and/or midodrine (2.5-10 mg two or three times per day). A second ABPM (ABPM2) was performed within 6 months and the results of ABPM1 AND ABPM2 were compared to assess the effects of BP-rising drugs.</p><p>RESULTS: In 32 patients assigned to fludrocortisone, 24-h SBP increased from 107.1 ± 9.9 mmHg to 116.3 ± 14.9 (p = 0.0001), the number of daily SBP drops &lt; 90 mmHg decreased by 73% (p = 0.0001) and that of drops &lt; 100 mmHg decreased by 41% (p = 0.0005). In 14 patients assigned to midodrine, 24-h SBP increased from 112.7 ± 7.4 mmHg to 115.0 ± 9.1 (p = 0.12), the number of daily SBP drops &lt; 90 mmHg decreased by 52% (p = 0.04) and that of drops &lt; 100 mmHg decreased by 34% (p = 0.007). In the seven patients taking both fludrocortisone and midodrine, 24-h SBP increased from 110.1 ± 11.5 mmHg to 114.0 ± 12.4 (p = 0.002), the number of daily SBP drops &lt; 90 mmHg decreased by 69% (p = 0.22) and that of drops &lt; 100 mmHg decreased by 44% (p = 0.04).</p><p>CONCLUSIONS: Both fludrocortisone and midodrine effectively increased 24-h SBP and reduced SBP drops on ABPM but fludrocortisone seemed to be more effective than midodrine. Further randomised studies are needed to confirm these observations.</p>}},
  author       = {{de Lange, Frederik J and van Zanten, Steven and Rivasi, Giulia and Groppelli, Antonella and Russo, Vincenzo and Maggi, Roberto and Capacci, Marco and Nawaz, Sara and Comune, Angelo and Ungar, Andrea and Parati, Gianfranco and Brignole, Michele and Fedorowski, Artur}},
  issn         = {{1619-1560}},
  language     = {{eng}},
  month        = {{12}},
  publisher    = {{Springer}},
  series       = {{Clinical autonomic research : official journal of the Clinical Autonomic Research Society}},
  title        = {{Haemodynamic effects of fludrocortisone and midodrine in patients with symptoms due to hypotension}},
  url          = {{http://dx.doi.org/10.1007/s10286-024-01096-3}},
  doi          = {{10.1007/s10286-024-01096-3}},
  year         = {{2024}},
}